| Name: | Montelukast Amide Impurity |
| Catalogue No. | VL510001 |
| CAS No. | 866923-63-9 |
| Molecular Formula | C₃₅H₃₇ClN₂O₂S |
| Molecular Weight | 585.2 |
| Status | In-stock |
| IUPAC Name | :1-[[[(1R)-1-[3-[(1E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]-cyclopropaneacetamide |
| Description | Montelukast Amide Impurity (CAS No: 866923-63-9) is an impurity present in the synthesis of montelukast which is a specific cysteinyl leukotriene receptor antagonist that belongs to the quinoline series which is used as a successful therapeutic agent for the treatment of bronchial asthma. |
| References | Saravanan, M., et al. “Identification, Synthesis, Isolation and Spectral Characterization of Potential Impurities of Montelukast Sodium.” Journal of Pharmaceutical and Biomedical Analysis, vol. 48, no. 3, Nov. 2008, pp. 708–15, https://doi.org/10.1016/j.jpba.2008.07.007. |
